Anu Medical Distributors

Product SpecificationPackaging Size100 MLDose76 %Injectable FormINJECTIONPackaging TypeVIALProduct TypeFinished ProductBrandTrazografProduct DescriptionINTRODUCTIONTrazograf 76% Infusion is used as a diagnostic agent. It is a dye injected into the body during various imaging tests, such as X-ray and angiography, to improve the visual of certain body parts.
Trazograf 76% Infusion is injected into the body by a doctor or a nurse during the various imaging procedure.  Following which it coats the organs, like the stomach and esophagus, making it easy to visualize the organs in X-ray or CT-scan examinations.
Use of this medicine may cause nausea, vomiting, diarrhea, and hives in few people. You should let your doctor know if you experience any such side effects.

We are a most trusted name among the top most companies in this business, involved in offering Contrast Media.

Ipobraz-370 Iopamidol Injection USP, marketed by Trident Medlife Pvt Ltd, is a non-ionic contrast agent used in diagnostic imaging. It improves the visibility of blood vessels, organs, and tissues during X-rays, CT scans, and angiographic procedures for accurate diagnosis.

Additional Information:

• Production Capacity: proper packing
• Delivery Time: 3-4 working days
• Packaging Details: 1pcs in (1-box)

• Active Ingredient: Iohexol USP (647 mg/mL, equivalent to 300 mg organically bound iodine per mL).
• Form: Liquid injectable solution.

Gadobutrol ( ) (Gd-DO3A-butrol) is a   (GBCA).gadobutrol injection is a magnetic resonance imaging (MRI) contrast agent that is used to help create a clear picture of the body during an MRI scan. MRI scans are a special kind of procedure that lets a doctor look at the inside of the body, such as the brain. They use magnets and computers to create images or “pictures” of the body. Unlike x-rays, MRI scans do not involve radiation. Gadobutrol is a gadolinium-based contrast agent (GBCA) that is given by injection before the MRI to help diagnose problems in the brain, spine, breast, and other parts of your body.Gadobutrol injection is also used for magnetic resonance angiography (MRA) to evaluate known or suspected supra-aortic or renal artery disease in adults and children. It is also used to assess how well blood flows through your heart (myocardial perfusion) and late gadolinium enhancement in adult patients with coronary artery disease (CAD).This medicine is to be given only by or under the direct supervision of your doctor.This product is available in the following dosage forms:SolutionCardiacGadavist® is approved for Cardiac Magnetic Resonance Imaging (CMRI) to assess myocardial perfusion (stress, rest) and late gadolinium enhancement in adult patients with known or suspected coronary artery disease (CAD).MRA IndicationThe first gadolinium-based contrast agent approved for magnetic resonance angiography (MRA) of the supra-aortic vasculature, Gadavist® is approved for use in MRA to evaluate known or suspected supra-aortic or renal artery disease in adult and pediatric patients including term neonates.Breast IndicationGadavist is the first GBCA specifically researched and developed for breast MRI in adult patients in 2 well-controlled clinical trials.CNSGadavist® is indicated for use with magnetic resonance imaging (MRI) in adult and pediatric patients including term neonates to detect and visualize areas with disrupted blood brain barrier and/or abnormal vascularity of the central nervous system. Gadavist received its indication in CNS for adults and pediatric patients 2 years of age and older in 2011 and in 2014 this was expanded to include patients less than 2 years of age, including term neonates.Pediatric ExpansionCNS approval was expanded in 2014 to include patients less than 2 years of age. Gadavist® is approved for use with magnetic resonance imaging (MRI) to detect and visualize areas with disrupted blood brain barrier and/or abnormal vascularity of the central nervous system in pediatric patients less than 2 years of age including term neonates.
gadobutrol

A gadolinium-based, hydrophilic, macrocyclic, electrically neutral contrast agent used in contrast-enhanced MRI (CE-MRI). Gadobutrol is a non-ionic, paramagnetic complex consisting of gadolinium (Gd3+) chelated with the macrocyclic compound dihydroxy-hydroxymethylpropyl-tetraazacyclododecane-triacetic acid (butrol). Following intravenous administration, gadobutrol may increase MRI sensitivity for the detection of tumors and inflammatory and demyelinating diseases of the central nervous system (CNS) which are associated with areas with blood-brain barrier defects due to altered perfusion or an enlarged extracellular space. This agent is eliminated in an unchanged form via the kidneys; extra-renal elimination is negligible.

• Sulfur Hexafluoride

• GradeLaboratory Grade
• Pack TypeVial
• BrandBracco
• Shelf Life36 Months
• SaltSulphur Hexafluoride
• UsageFor use with ultrasound imaging

• Contrast agent: A substance that contains iodine and is used to make certain parts of the body more visible on X-ray and CT scans.
• Generic Name: Iohexol.

• Gadopentetate dimeglumine Injection is indicated for use with magnetic resonance imaging (MRI) in adults, and pediatric patients (2 years of age and older) to visualize lesions with abnormal vascularity in the brain (intracranial lesions), spine and associated tissues. Gadopentetate dimeglumine Injection has been shown to facilitate visualization of intracranial lesions including but not limited to tumors
• Presentation : 10 ml, 20 ml vial
• Brainimage
• For Intravascular use only
• for MRI use only